United States — Food and Drug Administration & Zoetis

United States — Food and Drug Administration: The United States — Food and Drug Administration issued safety warnings concerning serious neurological complications in dogs related to Zoetis' Bedinvetmab, contributing to its weakening adoption.

Zoetis: Zoetis is facing a class action lawsuit for alleged securities fraud and unlawful business practices, which has negatively impacted its stock price and reputation. The company also cut its full-year 2026 profit guidance due to a challenging operating environment.

United States — Food and Drug Administration: The FDA issued safety warnings about neurological complications in dogs from Zoetis' Librela, which contributed to the alleged decline in prescriptions.

Zoetis: Zoetis is the defendant in the securities class action, facing allegations of misleading investors about its product performance. The lawsuit could lead to financial damages and reputational harm.

United States — Food and Drug Administration: The United States — Food and Drug Administration>>> granted emergency use authorization for several drugs to treat screwworm, aiding in the response to the outbreak.

Zoetis: Zoetis>>> shares also rose, benefiting from the potential increased spending on livestock drugs if the screwworm outbreak necessitates widespread treatment.